Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Recursion Pharmaceuticals Inc, Common Stock

RXRX

NSQ

$7.955

+$0.25

(3.25%)

Industry: Biotechnology Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$1.81B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

5.90M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

4.33M

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.75

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$4.54 L

$16.75 H

$7.955

About Recursion Pharmaceuticals Inc, Common Stock

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah. more

Industry: BiotechnologySector: Health Care

Returns

Time Frame	RXRX	Sector	S&P500
1-Week Return	1.72%	1.89%	0.45%
1-Month Return	-26.88%	-2.71%	-2.74%
3-Month Return	-27.63%	1.31%	4.65%
6-Month Return	35.09%	11.93%	21.21%
1-Year Return	42.59%	6.35%	24.48%
3-Year Return	-74.2%	19.71%	27.09%
5-Year Return	-75.4%	76.38%	87.75%

Time Frame	RXRX	Sector	S&P500
1-Week Return	143.33%	165.46%	26.38%
1-Month Return	-97.78%	-28.41%	-28.68%
3-Month Return	-73.06%	5.42%	20.24%
6-Month Return	84.02%	25.68%	47.71%
1-Year Return	42.59%	6.35%	24.48%
3-Year Return	-36.34%	6.18%	8.32%
5-Year Return	-24.46%	12.02%	13.43%

Financials

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	1.71M	3.41M	10.00M	39.68M	44.58M	[{"date":"2019-12-31","value":3.84,"profit":true},{"date":"2020-12-31","value":7.66,"profit":true},{"date":"2021-12-31","value":22.43,"profit":true},{"date":"2022-12-31","value":89.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	45.81M	63.32M	9.10M	48.27M	51.09M	[{"date":"2019-12-31","value":72.35,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":14.38,"profit":true},{"date":"2022-12-31","value":76.24,"profit":true},{"date":"2023-12-31","value":80.68,"profit":true}]
Gross Profit	(44.10M)	(59.91M)	10.00M	(8.59M)	(6.51M)	[{"date":"2019-12-31","value":-440.98,"profit":false},{"date":"2020-12-31","value":-599.06,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-85.94,"profit":false},{"date":"2023-12-31","value":-65.12,"profit":false}]
Gross Margin	(2577.32%)	(1755.23%)	100.00%	(21.66%)	(14.61%)	[{"date":"2019-12-31","value":-2577.32,"profit":false},{"date":"2020-12-31","value":-1755.23,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-21.66,"profit":false},{"date":"2023-12-31","value":-14.61,"profit":false}]

Operating Expenses	64.15M	88.03M	192.78M	237.13M	343.55M	[{"date":"2019-12-31","value":18.67,"profit":true},{"date":"2020-12-31","value":25.62,"profit":true},{"date":"2021-12-31","value":56.11,"profit":true},{"date":"2022-12-31","value":69.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(62.44M)	(84.61M)	(182.78M)	(245.73M)	(350.06M)	[{"date":"2019-12-31","value":-6244100000,"profit":false},{"date":"2020-12-31","value":-8461500000,"profit":false},{"date":"2021-12-31","value":-18277500000,"profit":false},{"date":"2022-12-31","value":-24572700000,"profit":false},{"date":"2023-12-31","value":-35006000000,"profit":false}]
Total Non-Operating Income/Expense	1.67M	(3.42M)	(6.58M)	12.45M	36.12M	[{"date":"2019-12-31","value":4.62,"profit":true},{"date":"2020-12-31","value":-9.45,"profit":false},{"date":"2021-12-31","value":-18.22,"profit":false},{"date":"2022-12-31","value":34.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	(61.88M)	(87.01M)	(186.48M)	(239.48M)	(332.13M)	[{"date":"2019-12-31","value":-6187900000,"profit":false},{"date":"2020-12-31","value":-8700600000,"profit":false},{"date":"2021-12-31","value":-18647900000,"profit":false},{"date":"2022-12-31","value":-23947600000,"profit":false},{"date":"2023-12-31","value":-33212800000,"profit":false}]
Income Taxes	646.00K	876.00K	(8.40M)	(55.00K)	(4.06M)	[{"date":"2019-12-31","value":73.74,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-959.47,"profit":false},{"date":"2022-12-31","value":-6.28,"profit":false},{"date":"2023-12-31","value":-463.7,"profit":false}]
Income After Taxes	(62.52M)	(87.88M)	(178.07M)	(239.42M)	(328.07M)	[{"date":"2019-12-31","value":-6252500000,"profit":false},{"date":"2020-12-31","value":-8788200000,"profit":false},{"date":"2021-12-31","value":-17807400000,"profit":false},{"date":"2022-12-31","value":-23942100000,"profit":false},{"date":"2023-12-31","value":-32806600000,"profit":false}]

Income From Continuous Operations	(61.88M)	(87.01M)	(186.48M)	(239.48M)	(292.56M)	[{"date":"2019-12-31","value":-6187900000,"profit":false},{"date":"2020-12-31","value":-8700600000,"profit":false},{"date":"2021-12-31","value":-18647900000,"profit":false},{"date":"2022-12-31","value":-23947600000,"profit":false},{"date":"2023-12-31","value":-29256200000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(62.52M)	(87.88M)	(178.07M)	(239.42M)	(328.07M)	[{"date":"2019-12-31","value":-6252500000,"profit":false},{"date":"2020-12-31","value":-8788200000,"profit":false},{"date":"2021-12-31","value":-17807400000,"profit":false},{"date":"2022-12-31","value":-23942100000,"profit":false},{"date":"2023-12-31","value":-32806600000,"profit":false}]

EPS (Diluted)	-	(0.25)	(2.30)	(1.37)	(1.57)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-25,"profit":false},{"date":"2021-12-31","value":-230,"profit":false},{"date":"2022-12-31","value":-137,"profit":false},{"date":"2023-12-31","value":-157,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	-	99.47%	193.00%	296.81%	12.33%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":33.51,"profit":true},{"date":"2021-12-31","value":65.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.16,"profit":true}]
Cost of Revenue	-	38.22%	(85.62%)	430.26%	5.82%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":8.88,"profit":true},{"date":"2021-12-31","value":-19.9,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":1.35,"profit":true}]
Gross Profit	-	35.85%	(116.69%)	(185.94%)	(24.23%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-325.53,"profit":false},{"date":"2022-12-31","value":-518.7,"profit":false},{"date":"2023-12-31","value":-67.58,"profit":false}]
Gross Margin	-	(31.90%)	(105.70%)	(121.66%)	(32.55%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Operating Expenses	-	37.22%	118.99%	23.01%	44.88%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":31.28,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":19.34,"profit":true},{"date":"2023-12-31","value":37.71,"profit":true}]
Operating Income	-	35.51%	116.01%	34.44%	42.46%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":30.61,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":29.69,"profit":true},{"date":"2023-12-31","value":36.6,"profit":true}]
Total Non-Operating Income/Expense	-	(304.74%)	92.77%	(289.12%)	190.15%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-160.26,"profit":false},{"date":"2021-12-31","value":48.79,"profit":true},{"date":"2022-12-31","value":-152.05,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	-	40.61%	114.33%	28.42%	38.69%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":35.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.86,"profit":true},{"date":"2023-12-31","value":33.84,"profit":true}]
Income Taxes	-	35.60%	(1059.47%)	(99.35%)	7285.45%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":0.49,"profit":true},{"date":"2021-12-31","value":-14.54,"profit":false},{"date":"2022-12-31","value":-1.36,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes	-	40.55%	102.63%	34.45%	37.02%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":39.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.57,"profit":true},{"date":"2023-12-31","value":36.08,"profit":true}]

Income From Continuous Operations	-	40.61%	114.33%	28.42%	22.17%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":35.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.86,"profit":true},{"date":"2023-12-31","value":19.39,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	40.55%	102.63%	34.45%	37.02%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":39.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.57,"profit":true},{"date":"2023-12-31","value":36.08,"profit":true}]

EPS (Diluted)	-	-	820.00%	(40.43%)	14.60%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-4.93,"profit":false},{"date":"2023-12-31","value":1.78,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	13.68M	12.13M	11.02M	10.10M	10.89M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":88.72,"profit":true},{"date":"2023-06-30","value":80.55,"profit":true},{"date":"2023-09-30","value":73.87,"profit":true},{"date":"2023-12-31","value":79.64,"profit":true}]
Cost of Revenue	10.84M	12.45M	9.38M	10.88M	23.48M	[{"date":"2022-12-31","value":46.16,"profit":true},{"date":"2023-03-31","value":53.01,"profit":true},{"date":"2023-06-30","value":39.96,"profit":true},{"date":"2023-09-30","value":46.32,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit	2.84M	(314.00K)	1.63M	(775.00K)	(12.59M)	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":-11.07,"profit":false},{"date":"2023-06-30","value":57.62,"profit":true},{"date":"2023-09-30","value":-27.33,"profit":false},{"date":"2023-12-31","value":-443.94,"profit":false}]
Gross Margin	20.74%	(2.59%)	14.83%	(7.67%)	(115.60%)	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":-12.48,"profit":false},{"date":"2023-06-30","value":71.53,"profit":true},{"date":"2023-09-30","value":-37,"profit":false},{"date":"2023-12-31","value":-557.46,"profit":false}]

Operating Expenses	63.82M	69.55M	83.35M	98.78M	96.54M	[{"date":"2022-12-31","value":64.61,"profit":true},{"date":"2023-03-31","value":70.41,"profit":true},{"date":"2023-06-30","value":84.38,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":97.74,"profit":true}]
Operating Income	(60.98M)	(69.86M)	(81.72M)	(99.55M)	(109.13M)	[{"date":"2022-12-31","value":-6098200000,"profit":false},{"date":"2023-03-31","value":-6986500000,"profit":false},{"date":"2023-06-30","value":-8171500000,"profit":false},{"date":"2023-09-30","value":-9955000000,"profit":false},{"date":"2023-12-31","value":-10913000000,"profit":false}]
Total Non-Operating Income/Expense	7.16M	9.18M	9.92M	6.53M	19.00M	[{"date":"2022-12-31","value":37.67,"profit":true},{"date":"2023-03-31","value":48.31,"profit":true},{"date":"2023-06-30","value":52.21,"profit":true},{"date":"2023-09-30","value":34.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	(57.49M)	(65.33M)	(76.73M)	(93.02M)	(94.62M)	[{"date":"2022-12-31","value":-5749200000,"profit":false},{"date":"2023-03-31","value":-6532700000,"profit":false},{"date":"2023-06-30","value":-7672600000,"profit":false},{"date":"2023-09-30","value":-9301700000,"profit":false},{"date":"2023-12-31","value":-9462400000,"profit":false}]
Income Taxes	(13.00K)	(4.54M)	(5.54M)	1.61M	(1.63M)	[{"date":"2022-12-31","value":-0.81,"profit":false},{"date":"2023-03-31","value":-282.57,"profit":false},{"date":"2023-06-30","value":-345.14,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-101.37,"profit":false}]
Income After Taxes	(57.48M)	(60.79M)	(71.18M)	(94.62M)	(93.00M)	[{"date":"2022-12-31","value":-5747900000,"profit":false},{"date":"2023-03-31","value":-6078900000,"profit":false},{"date":"2023-06-30","value":-7118300000,"profit":false},{"date":"2023-09-30","value":-9462300000,"profit":false},{"date":"2023-12-31","value":-9299600000,"profit":false}]

Income From Continuous Operations	(57.49M)	(65.33M)	(76.73M)	(93.02M)	(93.00M)	[{"date":"2022-12-31","value":-5749200000,"profit":false},{"date":"2023-03-31","value":-6532700000,"profit":false},{"date":"2023-06-30","value":-7672600000,"profit":false},{"date":"2023-09-30","value":-9301700000,"profit":false},{"date":"2023-12-31","value":-9299600000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(57.48M)	(60.79M)	(76.73M)	(93.02M)	(93.00M)	[{"date":"2022-12-31","value":-5747900000,"profit":false},{"date":"2023-03-31","value":-6078900000,"profit":false},{"date":"2023-06-30","value":-7672600000,"profit":false},{"date":"2023-09-30","value":-9301700000,"profit":false},{"date":"2023-12-31","value":-9299600000,"profit":false}]

EPS (Diluted)	(0.31)	(0.34)	(0.38)	(0.43)	(0.42)	[{"date":"2022-12-31","value":-31,"profit":false},{"date":"2023-03-31","value":-34,"profit":false},{"date":"2023-06-30","value":-38,"profit":false},{"date":"2023-09-30","value":-43,"profit":false},{"date":"2023-12-31","value":-42,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	-	(11.28%)	(9.21%)	(8.30%)	7.81%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-144.36,"profit":false},{"date":"2023-06-30","value":-117.97,"profit":false},{"date":"2023-09-30","value":-106.23,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	14.83%	(24.63%)	15.93%	115.88%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":12.8,"profit":true},{"date":"2023-06-30","value":-21.26,"profit":false},{"date":"2023-09-30","value":13.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit	-	(111.07%)	(620.38%)	(147.43%)	1524.52%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-7.29,"profit":false},{"date":"2023-06-30","value":-40.69,"profit":false},{"date":"2023-09-30","value":-9.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	-	(112.48%)	(673.20%)	(151.72%)	1406.83%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-8,"profit":false},{"date":"2023-06-30","value":-47.85,"profit":false},{"date":"2023-09-30","value":-10.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	-	8.98%	19.84%	18.51%	(2.26%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":45.28,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":93.29,"profit":true},{"date":"2023-12-31","value":-11.41,"profit":false}]
Operating Income	-	14.57%	16.96%	21.83%	9.62%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":66.74,"profit":true},{"date":"2023-06-30","value":77.71,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":44.09,"profit":true}]
Total Non-Operating Income/Expense	-	28.22%	8.07%	(34.14%)	190.86%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":14.78,"profit":true},{"date":"2023-06-30","value":4.23,"profit":true},{"date":"2023-09-30","value":-17.89,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	-	13.63%	17.45%	21.23%	1.73%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":64.18,"profit":true},{"date":"2023-06-30","value":82.18,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":8.14,"profit":true}]
Income Taxes	-	34807.69%	22.15%	(128.97%)	(201.37%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":0.06,"profit":true},{"date":"2023-09-30","value":-0.37,"profit":false},{"date":"2023-12-31","value":-0.58,"profit":false}]
Income After Taxes	-	5.76%	17.10%	32.93%	(1.72%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":17.49,"profit":true},{"date":"2023-06-30","value":51.92,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-5.22,"profit":false}]

Income From Continuous Operations	-	13.63%	17.45%	21.23%	(0.02%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":64.18,"profit":true},{"date":"2023-06-30","value":82.18,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-0.11,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	5.76%	26.22%	21.23%	(0.02%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":21.97,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":80.99,"profit":true},{"date":"2023-12-31","value":-0.09,"profit":false}]

EPS (Diluted)	-	9.68%	11.76%	13.16%	(2.33%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":73.55,"profit":true},{"date":"2023-06-30","value":89.41,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-17.67,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	76.40M	269.48M	534.72M	569.81M	438.14M	[{"date":"2019-12-31","value":13.41,"profit":true},{"date":"2020-12-31","value":47.29,"profit":true},{"date":"2021-12-31","value":93.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.89,"profit":true}]
Non-current Assets	25.03M	29.11M	75.63M	131.47M	215.56M	[{"date":"2019-12-31","value":11.61,"profit":true},{"date":"2020-12-31","value":13.5,"profit":true},{"date":"2021-12-31","value":35.08,"profit":true},{"date":"2022-12-31","value":60.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	101.43M	298.58M	610.35M	701.29M	653.70M	[{"date":"2019-12-31","value":14.46,"profit":true},{"date":"2020-12-31","value":42.58,"profit":true},{"date":"2021-12-31","value":87.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.21,"profit":true}]

Total Liabilities
Current Liabilities	6.68M	23.10M	46.66M	100.27M	93.17M	[{"date":"2019-12-31","value":6.67,"profit":true},{"date":"2020-12-31","value":23.04,"profit":true},{"date":"2021-12-31","value":46.53,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.92,"profit":true}]
Non-current Liabilities	219.01M	481.77M	20.75M	115.22M	97.09M	[{"date":"2019-12-31","value":45.46,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":4.31,"profit":true},{"date":"2022-12-31","value":23.92,"profit":true},{"date":"2023-12-31","value":20.15,"profit":true}]
Total Liabilities	225.70M	504.87M	67.41M	215.48M	190.26M	[{"date":"2019-12-31","value":44.7,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":13.35,"profit":true},{"date":"2022-12-31","value":42.68,"profit":true},{"date":"2023-12-31","value":37.69,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	2.00K	2.00K	2.00K	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(126.59M)	(213.60M)	(400.08M)	(639.56M)	(967.62M)	[{"date":"2019-12-31","value":-12659500000,"profit":false},{"date":"2020-12-31","value":-21360100000,"profit":false},{"date":"2021-12-31","value":-40008000000,"profit":false},{"date":"2022-12-31","value":-63955600000,"profit":false},{"date":"2023-12-31","value":-96762200000,"profit":false}]
Other Stockholders' Equity	(198.78M)	(441.00M)	332.80M	1.13B	1.43B	[{"date":"2019-12-31","value":-13.89,"profit":false},{"date":"2020-12-31","value":-30.82,"profit":false},{"date":"2021-12-31","value":23.26,"profit":true},{"date":"2022-12-31","value":78.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	(124.27M)	(206.29M)	542.94M	485.81M	463.44M	[{"date":"2019-12-31","value":-22.89,"profit":false},{"date":"2020-12-31","value":-37.99,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.48,"profit":true},{"date":"2023-12-31","value":85.36,"profit":true}]

Total Liabilities & Shareholders Equity	101.43M	298.58M	610.35M	701.29M	653.70M	[{"date":"2019-12-31","value":14.46,"profit":true},{"date":"2020-12-31","value":42.58,"profit":true},{"date":"2021-12-31","value":87.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.21,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	-	252.73%	98.43%	6.56%	(23.11%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":38.95,"profit":true},{"date":"2022-12-31","value":2.6,"profit":true},{"date":"2023-12-31","value":-9.14,"profit":false}]
Non-current Assets	-	16.27%	159.82%	73.85%	63.96%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":10.18,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":46.2,"profit":true},{"date":"2023-12-31","value":40.02,"profit":true}]
Total Assets	-	194.37%	104.41%	14.90%	(6.79%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":53.72,"profit":true},{"date":"2022-12-31","value":7.67,"profit":true},{"date":"2023-12-31","value":-3.49,"profit":false}]

Total Liabilities
Current Liabilities	-	245.59%	101.99%	114.89%	(7.08%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":41.53,"profit":true},{"date":"2022-12-31","value":46.78,"profit":true},{"date":"2023-12-31","value":-2.88,"profit":false}]
Non-current Liabilities	-	119.98%	(95.69%)	455.29%	(15.73%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":26.35,"profit":true},{"date":"2021-12-31","value":-21.02,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3.46,"profit":false}]
Total Liabilities	-	123.70%	(86.65%)	219.67%	(11.70%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":56.31,"profit":true},{"date":"2021-12-31","value":-39.44,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.33,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	68.73%	87.30%	59.86%	51.30%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":78.72,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":68.56,"profit":true},{"date":"2023-12-31","value":58.76,"profit":true}]
Other Stockholders' Equity	-	121.85%	(175.46%)	238.15%	27.16%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":51.17,"profit":true},{"date":"2021-12-31","value":-73.68,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":11.41,"profit":true}]
Total Shareholders' equity	-	66.01%	(363.19%)	(10.52%)	(4.60%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-550.23,"profit":false},{"date":"2022-12-31","value":-15.94,"profit":false},{"date":"2023-12-31","value":-6.98,"profit":false}]

Total Liabilities & Shareholders Equity	-	194.37%	104.41%	14.90%	(6.79%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":53.72,"profit":true},{"date":"2022-12-31","value":7.67,"profit":true},{"date":"2023-12-31","value":-3.49,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	569.81M	492.13M	431.02M	410.52M	438.14M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":86.37,"profit":true},{"date":"2023-06-30","value":75.64,"profit":true},{"date":"2023-09-30","value":72.04,"profit":true},{"date":"2023-12-31","value":76.89,"profit":true}]
Non-current Assets	131.47M	135.24M	235.68M	220.30M	215.56M	[{"date":"2022-12-31","value":55.79,"profit":true},{"date":"2023-03-31","value":57.38,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":93.48,"profit":true},{"date":"2023-12-31","value":91.46,"profit":true}]
Total Assets	701.29M	627.37M	666.70M	630.83M	653.70M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":89.46,"profit":true},{"date":"2023-06-30","value":95.07,"profit":true},{"date":"2023-09-30","value":89.95,"profit":true},{"date":"2023-12-31","value":93.21,"profit":true}]

Total Liabilities
Current Liabilities	100.27M	92.15M	113.96M	94.12M	93.17M	[{"date":"2022-12-31","value":87.98,"profit":true},{"date":"2023-03-31","value":80.86,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":82.59,"profit":true},{"date":"2023-12-31","value":81.76,"profit":true}]
Non-current Liabilities	115.22M	105.04M	83.78M	98.74M	97.09M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":91.17,"profit":true},{"date":"2023-06-30","value":72.71,"profit":true},{"date":"2023-09-30","value":85.7,"profit":true},{"date":"2023-12-31","value":84.27,"profit":true}]
Total Liabilities	215.48M	197.19M	197.74M	192.86M	190.26M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":91.51,"profit":true},{"date":"2023-06-30","value":91.76,"profit":true},{"date":"2023-09-30","value":89.5,"profit":true},{"date":"2023-12-31","value":88.3,"profit":true}]

Total Shareholders' equity
Common Stock	2.00K	2.00K	2.00K	2.00K	2.00K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(639.56M)	(704.88M)	(781.61M)	(874.63M)	(967.62M)	[{"date":"2022-12-31","value":-63955600000,"profit":false},{"date":"2023-03-31","value":-70488300000,"profit":false},{"date":"2023-06-30","value":-78160900000,"profit":false},{"date":"2023-09-30","value":-87462600000,"profit":false},{"date":"2023-12-31","value":-96762200000,"profit":false}]
Other Stockholders' Equity	1.13B	1.14B	1.25B	1.31B	1.43B	[{"date":"2022-12-31","value":78.64,"profit":true},{"date":"2023-03-31","value":79.32,"profit":true},{"date":"2023-06-30","value":87.39,"profit":true},{"date":"2023-09-30","value":91.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	485.81M	430.18M	468.96M	437.97M	463.44M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":88.55,"profit":true},{"date":"2023-06-30","value":96.53,"profit":true},{"date":"2023-09-30","value":90.15,"profit":true},{"date":"2023-12-31","value":95.4,"profit":true}]

Total Liabilities & Shareholders Equity	701.29M	627.37M	666.70M	630.83M	653.70M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":89.46,"profit":true},{"date":"2023-06-30","value":95.07,"profit":true},{"date":"2023-09-30","value":89.95,"profit":true},{"date":"2023-12-31","value":93.21,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	-	(13.63%)	(12.42%)	(4.76%)	6.73%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-202.68,"profit":false},{"date":"2023-06-30","value":-184.58,"profit":false},{"date":"2023-09-30","value":-70.7,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	2.87%	74.27%	(6.52%)	(2.15%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":3.86,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-8.78,"profit":false},{"date":"2023-12-31","value":-2.9,"profit":false}]
Total Assets	-	(10.54%)	6.27%	(5.38%)	3.63%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-168.13,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-85.83,"profit":false},{"date":"2023-12-31","value":57.84,"profit":true}]

Total Liabilities
Current Liabilities	-	(8.09%)	23.67%	(17.41%)	(1.01%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-34.2,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-73.57,"profit":false},{"date":"2023-12-31","value":-4.25,"profit":false}]
Non-current Liabilities	-	(8.83%)	(20.24%)	17.86%	(1.67%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-49.45,"profit":false},{"date":"2023-06-30","value":-113.34,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-9.34,"profit":false}]
Total Liabilities	-	(8.49%)	0.28%	(2.47%)	(1.35%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-3071.26,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-892.58,"profit":false},{"date":"2023-12-31","value":-486.84,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	10.21%	10.88%	11.90%	10.63%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":85.83,"profit":true},{"date":"2023-06-30","value":91.46,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":89.34,"profit":true}]
Other Stockholders' Equity	-	0.86%	10.18%	4.96%	9.03%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":8.47,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":48.73,"profit":true},{"date":"2023-12-31","value":88.68,"profit":true}]
Total Shareholders' equity	-	(11.45%)	9.02%	(6.61%)	5.82%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-127,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-73.3,"profit":false},{"date":"2023-12-31","value":64.49,"profit":true}]

Total Liabilities & Shareholders Equity	-	(10.54%)	6.27%	(5.38%)	3.63%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-168.13,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-85.83,"profit":false},{"date":"2023-12-31","value":57.84,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	(57.04M)	(45.40M)	(158.61M)	(83.52M)	(287.78M)	[{"date":"2019-12-31","value":-5704200000,"profit":false},{"date":"2020-12-31","value":-4539900000,"profit":false},{"date":"2021-12-31","value":-15861400000,"profit":false},{"date":"2022-12-31","value":-8352400000,"profit":false},{"date":"2023-12-31","value":-28778000000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(3.91M)	(8.74M)	(271.74M)	193.25M	-	[{"date":"2019-12-31","value":-2.02,"profit":false},{"date":"2020-12-31","value":-4.52,"profit":false},{"date":"2021-12-31","value":-140.62,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	120.41M	246.13M	458.54M	154.34M	140.13M	[{"date":"2019-12-31","value":26.26,"profit":true},{"date":"2020-12-31","value":53.68,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.66,"profit":true},{"date":"2023-12-31","value":30.56,"profit":true}]

Net Change in Cash	59.46M	192.00M	28.18M	263.76M	(156.40M)	[{"date":"2019-12-31","value":22.54,"profit":true},{"date":"2020-12-31","value":72.79,"profit":true},{"date":"2021-12-31","value":10.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-59.29,"profit":false}]

Free Cash Flow
Free Cash Flow	(60.95M)	(52.13M)	(198.41M)	(120.88M)	(300.33M)	[{"date":"2019-12-31","value":-6095200000,"profit":false},{"date":"2020-12-31","value":-5213400000,"profit":false},{"date":"2021-12-31","value":-19841200000,"profit":false},{"date":"2022-12-31","value":-12088300000,"profit":false},{"date":"2023-12-31","value":-30033200000,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(20.41%)	249.38%	(47.34%)	244.55%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-8.18,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-18.98,"profit":false},{"date":"2023-12-31","value":98.06,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	123.53%	3009.20%	(171.11%)	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":4.11,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-5.69,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	104.41%	86.30%	(66.34%)	(9.21%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.65,"profit":true},{"date":"2022-12-31","value":-63.54,"profit":false},{"date":"2023-12-31","value":-8.82,"profit":false}]

Net Change in Cash	-	222.91%	(85.32%)	835.93%	(159.29%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":26.67,"profit":true},{"date":"2021-12-31","value":-10.21,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-19.06,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(14.47%)	280.58%	(39.07%)	148.45%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-5.16,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-13.93,"profit":false},{"date":"2023-12-31","value":52.91,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	(44.75M)	(73.32M)	(67.47M)	(72.92M)	(74.08M)	[{"date":"2022-12-31","value":-4474800000,"profit":false},{"date":"2023-03-31","value":-7331600000,"profit":false},{"date":"2023-06-30","value":-6746700000,"profit":false},{"date":"2023-09-30","value":-7292000000,"profit":false},{"date":"2023-12-31","value":-7407700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(7.98M)	(5.34M)	(2.05M)	-	-	[{"date":"2022-12-31","value":-797900000,"profit":false},{"date":"2023-03-31","value":-534000000,"profit":false},{"date":"2023-06-30","value":-205300000,"profit":false},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	147.26M	1.92M	3.79M	53.77M	80.66M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":1.31,"profit":true},{"date":"2023-06-30","value":2.57,"profit":true},{"date":"2023-09-30","value":36.51,"profit":true},{"date":"2023-12-31","value":54.77,"profit":true}]

Net Change in Cash	94.22M	(76.74M)	(65.55M)	(19.62M)	5.22M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":-81.44,"profit":false},{"date":"2023-06-30","value":-69.57,"profit":false},{"date":"2023-09-30","value":-20.82,"profit":false},{"date":"2023-12-31","value":5.54,"profit":true}]

Free Cash Flow
Free Cash Flow	(52.73M)	(78.66M)	(71.44M)	(73.75M)	(76.49M)	[{"date":"2022-12-31","value":-5272700000,"profit":false},{"date":"2023-03-31","value":-7865600000,"profit":false},{"date":"2023-06-30","value":-7143500000,"profit":false},{"date":"2023-09-30","value":-7374700000,"profit":false},{"date":"2023-12-31","value":-7649400000,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	-	63.84%	(7.98%)	8.08%	1.59%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-12.5,"profit":false},{"date":"2023-09-30","value":12.66,"profit":true},{"date":"2023-12-31","value":2.49,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(33.07%)	(61.55%)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(98.69%)	97.03%	1319.73%	50.02%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-7.48,"profit":false},{"date":"2023-06-30","value":7.35,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":3.79,"profit":true}]

Net Change in Cash	-	(181.44%)	(14.57%)	(70.07%)	(126.60%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	49.18%	(9.18%)	3.24%	3.72%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-18.67,"profit":false},{"date":"2023-09-30","value":6.58,"profit":true},{"date":"2023-12-31","value":7.57,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	RXRX
Cash Ratio	4.24
Current Ratio	4.70

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	RXRX
ROA (LTM)	-32.29%
ROE (LTM)	-69.12%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	RXRX
Debt Ratio Lower is generally better. Negative is bad.	0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.71
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is.	1.41

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	RXRX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	44.27
P/B	4.26
Price/FCF	NM
EV/R	37.26
EV/Ebitda	NM
PEG	0.34

News

Recursion Pharmaceuticals (NASDAQ:RXRX) AI-Driven Drug Discovery Offers Promising Upside

In 1953, James Watson and Francis Crick revealed the double-helix DNA structure, but mapping the human genome awaited computing advances, achieved …

24 Apr, 2024 a 3:45 am TipRanks

Lightning Round: Casey''s General Store is a ''hidden gem'', says Jim Cramer

''Mad Money'' host Jim Cramer weighs in on stock including: PBR, Enterprise Products, Recursion Pharma, Cheniere Energy, Casey''s General Store and more.

23 Apr, 2024 a 11:57 pm CNBC

Where Will Recursion Pharmaceuticals Be in 5 Years?

A lot is riding on whether its platform is valuable, or vaporware.

17 Apr, 2024 a 11:00 am The Motley Fool

Recursion Pharmaceuticals Welcomes New Director and C-Suite Executive

Recursion Pharmaceuticals (RXRX) just unveiled an update. Recursion Pharmaceuticals, Inc. has expanded its Board of Directors to nine members, welc…

16 Apr, 2024 a 12:12 pm TipRanks

Recursion Pharmaceuticals, Inc.: Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion''s Board of DirectorsSALT LA…

16 Apr, 2024 a 12:10 pm Finanz Nachrichten

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential

The broader medical therapeutic sector is already volatile so it stands to reason in some sense to consider under-$10 biotech stocks . Imagine you acquired shares of a popular, richly priced enterprise, only for the underlying security to suffer due to a poor clinical result. And poor results can happen to anybody, big or small. Indeed, the prospect of being on the wrong end of a giant killing adds significant risk to market participants. So, as a calculated approach, since you’re going to be taking huge risks anyways, you might as well go for ideas with the substantial upside return potential. On that note, below are under-$10 biotech stocks to consider. Actinium Pharmaceuticals (ATNM) Source: Gorodenkoff / Shutterstock.com Based in New York, Actinium Pharmaceuticals (NYSEAMERICAN: ATNM ) is a clinical-stage biopharmaceutical company developing targeted radiotherapies . Specifically, it delivers cancer-killing radiation to treat patients with high unmet medical needs. Actinium features a product candidate which is in Phase 3 clinical trials for elderly relapsed or refractory acute myeloid leukemia.

15 Apr, 2024 a 4:54 pm InvestorPlace

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for April 2024

Known for her focus on innovative disruption, Cathie Wood has become one of the biggest names in capital management. With her firm, ARK Invest, Wood has created custom exchange-traded funds focused on aggregating high-potential stocks. Much of her portfolio focuses on technologies like genomics, artificial intelligence, robotics, clean energy and blockchain technology. This makes for an ETF group that boasts some serious growth over the last ten years of Wood’s fund management. However, these stocks are not without their risks. Disruptive companies tend to command a high share price due to the level of impact they presently drive. That performance may not always last long enough to keep growth steady, but it can help inform future investing decisions. For investors and analysts alike, taking a close look at Cathie Wood’s stocks could be a good way to assess return potential. As such, here are three of the stocks that make up the Ark Invest portfolio and my thoughts on why Wood picked them.

15 Apr, 2024 a 12:00 pm InvestorPlace

Can Recursion Pharmaceuticals Stock Double in 5 Years? Here''s What It Would Take.

Recursion is playing the long game with its AI-focused approach to drug discovery and development.

10 Apr, 2024 a 9:50 am The Motley Fool

Nvidia Didn’t Talk About This at GTC

Hello, Reader. If I described a heavily attended, several-day event that celebrated cultural change and new ideas… you might think of the 1969 rock festival Woodstock. Although a little bit less rock ’n’ roll, I’m actually talking about the GPU Technology Conference (GTC) – dubbed the “AI Woodstock” – held by Nvidia Corp. ( NVDA ) . The company’s 2024 GTC meeting kicked off yesterday, attended by hundreds of thousands of in-person and virtual investors and developers. During Nvidia CEO Jensen Huang’s keynote address, he introduced the company’s new AI processor, Blackwell. That, he says, is the “world’s most powerful chip” for AI. Rock on. But with the advent of Blackwell chips, I can’t help but wonder… What else Nvidia doing? So, in today’s Smart Money , I’ll explore that weighty question. The answer could lead to some surprising investment insights. And where it’s hidden might actually surprise you… Hidden in Plain… Earnings Report On February 21, Nvidia reported the latest of its by-now monotonously amazing earnings reports.

19 Mar, 2024 a 7:30 pm InvestorPlace

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Recursion Pharmaceuticals Inc share price today?

Recursion Pharmaceuticals Inc (RXRX) share price today is $7.955

Can Indians buy Recursion Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Recursion Pharmaceuticals Inc (RXRX) on Vested. To buy Recursion Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RXRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Recursion Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Recursion Pharmaceuticals Inc (RXRX) via the Vested app. You can start investing in Recursion Pharmaceuticals Inc (RXRX) with a minimum investment of $1.

How to invest in Recursion Pharmaceuticals Inc shares from India?

You can invest in shares of Recursion Pharmaceuticals Inc (RXRX) via Vested in three simple steps:

Click on Sign Up or Invest in RXRX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Recursion Pharmaceuticals Inc shares

What is Recursion Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Recursion Pharmaceuticals Inc (RXRX) is $16.75. The 52-week low price of Recursion Pharmaceuticals Inc (RXRX) is $4.54.

What is Recursion Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Recursion Pharmaceuticals Inc (RXRX) is NM

What is Recursion Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Recursion Pharmaceuticals Inc (RXRX) is 4.26

What is Recursion Pharmaceuticals Inc dividend yield?

The dividend yield of Recursion Pharmaceuticals Inc (RXRX) is 0.00%

What is the Market Cap of Recursion Pharmaceuticals Inc?

The market capitalization of Recursion Pharmaceuticals Inc (RXRX) is $1.81B

What is Recursion Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Recursion Pharmaceuticals Inc is RXRX

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

Recursion Pharmaceuticals Inc, Common Stock

RXRX

NSQ

$7.955

+$0.25

(3.25%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Recursion Pharmaceuticals Inc, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

News

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²